Personalized Medicine Market Size & Trends To 2030 11-26-2024 07:48 PM CET | Health & Medicine Press release from: Prudent Markets The Personalized Medicine Market 2024 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global Personalized Medicine market. This report explores all the key factors affecting the growth of the global Personalized Medicine market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis. The report concludes with the profiles of major players in the Personalized Medicine market are: Abbott Laboratories, ASURAGEN, INC., bioMerieux SA, Bristol-Myers Squibb, CETICS Healthcare Technologies GmbH, GlaxoSmithKline, IBM Corporation, Illumina, Inc., Intomics A/S, JOHNSON & JOHNSON, Laboratory Corporation of America, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Quest Diagnostics, Randox Laboratories, SANOFI, Almac Group, Amgen, Inc., Astellas Pharma, Inc., AstraZeneca PLC , Teva Pharmaceuticals Limited, Thermo Fisher Scientific Discover Who You Really Compete Against In The Marketplace, Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/22972/ Personalized Medicine Market Segmentation are: Application(Health Informatics, Clinical Research, Companion Diagnostics, Biomarker Identification), By End-user(Hospitals, Contract Research Organizations, Molecular Diagnostic Laboratories and Testing facilities Academic Institutes and Research Laboratories, Bio and health informatics companies), By Therapeutic Area(Cardiology, Antiviral, Psychiatry, Oncology, Neurology), Industry Trends, Estimation & Forecast, 2017 - 2025 Personalized Medicine Market 2018-2026 report is a professional study on the current state of the market that focuses on the major drivers, challenges, opportunities for the leading players. The research report also offers a granular analysis of various definitions, and classification of the industry, applications of the industry, regional breakdown, opportunities, challenges, and chain structure. About Personalized Medicine Market Personalized medication is an advanced version of the conventional approaches for the treatment of diseases on an individual level. It is a process of diagnosing and preventing a disease by providing treatment to a patient using the information regarding his/her genetic structure, proteins, and the external environment. Its a methodology which is based upon the analysis of unique risks associated to a specific person regarding specific diseases. The major advantage of this medicine therapy is that, it incorporates the usage of highly precise equipment and tools, coupled with specialized doctors who determine the treatment on the basis of patients molecular profile after the analysis of harmful side effects. This saves the patient from unnecessary delay in the treatment and extra cost which is caused by the conventional trial and error approach. There are various funded programs supported by the European Union for the development of biotechnology research and personalized medicine. For example, the EU has already sanctioned a fund of more than 3 billion euros for the personalized medication research. Market Summary: The Personalized Medicine market is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Personalized Medicine Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market. The study on the worldwide Personalized Medicine market strives to offer substantial and profound insights into the current market scenario and the developing growth dynamics. Moreover, the report also provides the market players along with the new contenders a complete view of the market landscape. The inclusive research will enable the well-established as well as the entry-level players to establish their business strategies and accomplish their short-term and long-term goals. Scope and Segmentation of the Report Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs. Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/22972/ The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global Personalized Medicine Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market. Regional Analysis for Personalized Medicine Market: • North America (the USA and Canada) • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) • Latin America (Brazil, Mexico and Rest of Latin America) • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa) TO KNOW MORE ABOUT COVID-19 IMPACT @ https://www.prudentmarkets.com/sample-request/22972/ Strategic Points Covered in Table of Content of Global Personalized Medicine Market: Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Personalized Medicine market Chapter 2: Exclusive Summary - the basic information of the Personalized Medicine Market. Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Personalized Medicine Chapter 4: Presenting the Personalized Medicine Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis. Chapter 5: Displaying the by Type, End User and Region/Country Chapter 6: Evaluating the leading manufacturers of the Personalized Medicine market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source Why should you purchase this report? -Prudent Markets provides the vital historical and analysis data of global Personalized Medicine market. -The report provides the entire assessment of the future market and altering market scenario or behavior. -All the business decision could be backed through the several strategic business methodologies offered in the report. -An extra edge in the competitive market could be obtained from this elaborative research report -The report offers all the competitive landscape, growth drivers, applications, market dynamics, and other necessary details as well. For In-Depth Competitive Analysis - Purchase this Report now at a Complete Table of Contents (Single User License) @ https://www.prudentmarkets.com/checkout/?id=22972&license_type=su Free Customization on the basis of client requirements on Immediate purchase: 1- Free country-level breakdown of any 5 countries of your interest. 2- Competitive breakdown of segment revenue by market players. Customization of the Report: This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements. Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis. In conclusion, the Personalized Medicine Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report. https://www.linkedin.com/pulse/analysis-tablet-disintegration-testers-market-its-y8mhc/ https://www.linkedin.com/pulse/understanding-factors-influencing-desktop-sls-printer-8iswc/ https://www.linkedin.com/pulse/understanding-factors-influencing-custom-keycaps-xssbe/ https://www.linkedin.com/pulse/comprehensive-review-heat-conduction-co2-vm85e/ https://www.linkedin.com/pulse/comprehensive-review-motor-starters-market-4fnlc/ Contact Us: Allan Carter Andheri, Maharashtra, 400102 USA/Canada(Toll Free): 1800-601-6071 Direct Line: +91 83560 50278 Mail: sales@prudentmarkets.com Web: www.prudentmarkets.com About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.
Big Ten could place four teams in playoff, thanks to IU's riseOrthopedic Implants Market to Hit USD 26.47 Billion by 2029 with 4.8% CAGR 12-17-2024 12:22 AM CET | Health & Medicine Press release from: ABNewswire prominent players in the orthopedic implants market are Stryker Corporation (US), Zimmer Biomet Holdings, Inc. (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany). Browse 163 market data Tables and 60 Figures spread through 259 Pages and in-depth TOC on "Orthopedic Implants Market by Product (Knee, Hip, Elbow, Ankle, Shoulder, Foot, Wrist), Material (Metals: Stainless Steel, Titanium Alloy, Cobalt Chromium, Nitinol; Polymers, Ceramics, Hybrid), End user (Hospitals, ASCs, Trauma) - Global Forecast to 2029 The global orthopedic implants market [ https://www.marketsandmarkets.com/Market-Reports/orthopedic-implants-market-5230937.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=orthopedicimplantsmarket ] is projected to grow USD 26.47 billion in 2029 from USD 20.94 billion in 2024, at a CAGR of 4.8% from 2024 to 2029. Technology improvements, rising opportunities in developing markets, increase in prevalence of orthopedic disorders, and the increasing old-age population are contributing factors to the growth of orthopedic implant market. Orthopedic disorders such osteoarthritis, osteoporosis, and fractures are more likely to occur in geriatric people. The need for orthopedic implants to improve mobility and quality of life with these problems has increased because of the demographic transition. Along with the market's steady growth, there has been a rise in the number of orthopedic procedures and awareness related to the benefits of orthopedic surgeries. Download PDF Brochure: [ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5230937&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=orthopedicimplantsmarket ] Browse in-depth TOC on "Orthopedic Implants Market"163 - Tables60 - Figures259 - Pages The orthopedic implants market is segmented based on type into knee implants, hip implants, shoulder implants, elbow implants, foot & ankle implants, wrist implants, and other implants - knee segment is expected to hold major share of the market in 2023. The increase in number of revision knee surgical procedures and rising prevalence of knee osteoarthritis is driving the growth of this segment. According to NHS inform more than 70,000 knee replacements are performed in England and Wales each year. In 2022, the primary and revision hip and knee arthroplasty procedures performed are 3,149,042 during the time of 2012 and 2022 which is 23% growth in procedural cases (Source: American Academy of Orthopedic Surgeons). By material, the orthopedic implants market is segmented into metal and metal alloys, ceramics, polymers and hybrid implants. In 2023, the metal and metal alloys segment held a significant share of the market 2023. The growth in this segment is driven by high strength and resistance to wear than any other material. Many of the metal alloys are compatible to imaging methods such as X-rays and CT scan that help in postoperative monitoring further supporting the growth of the segment. Regarding end users, the orthopedic implants market is fragmented into hospitals & surgical centers and ambulatory & trauma care centers. The major share of the market was contributed by hospitals & surgical centers segment in 2023. Increasing funding opportunities and rising focus on healthcare research by private and public entities are fuelling the market's growth. Furthermore, increasing number of hospitals which are equipped with advanced surgical equipment support the growth of the segment. The orthopedic implants market is segmented by region into Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America region accounted for the major market share, followed by Europe and Asia Pacific. The significant share of North America in this market is attributed to the strong existence of key players, rising number of fractures, increasing medical tourism. Factors such as increasing healthcare expenditure and growing popularity for various orthopedic treatments support the market growth in this region. Request Sample Pages: [ https://www.marketsandmarkets.com/requestsampleNew.asp?id=5230937&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=orthopedicimplantsmarket ] The orthopedic implants market is consolidated. As of 2023, the key players operating in the global orthopedic implants market are Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany). In 2023, Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US) held a major share of the orthopedic implants market. These players have adopted key strategies such as acquisitions, partnerships, and expansions in the last four to five years. Stryker Corporation (US): Stryker Corporation is among the leading companies in the global the company has a strong presence in North America, Europe, the Middle East, Africa, and the Asia Pacific, with its brand presence in more than 75 countries across the globe market. The company has a strong presence in North America, Europe, the Middle East, Africa, and the Asia Pacific, with its brand presence in more than 75 countries across the globe. The company offers orthopedic implants through other Orthopedics & Spine division segment. The company focuses on enhancing its product portfolio and continuous innovation and developing new products to sustain its leading position in the market. Zimmer Biomet Holdings, Inc. (US): Zimmer Biomet is a medical device company that develops, manufactures, and markets a wide range of healthcare products. The company offers orthopedic implants through its Knees, Hips, and S.E.T segments. The company has a strong geographic presence across countries such as France, Germany, Italy, Spain, the UK, Switzerland, Japan, Australia, New Zealand, South Korea, China, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. Also, the company has a wide distribution network across Benelux, Nordic, Central & Eastern Europe, and the Middle East & Africa. Zimmer Biomet has a strong brand value among orthopedic implants end users, strong R&D capabilities, and a robust product portfolio. Johnson & Johnson MedTech (US): Johnson & Johnson MedTech is another major player operating in the orthopedic implants market. The company is engaged in the R&D, manufacturing, and marketing of orthopedic implants and other healthcare products across the globe. It offers orthopedic implants under the MedTech business segment. The company is dedicated to research & innovation to forge and unveil novel offerings that optimize patient results. The company collaborated with CrossRoads Extremity Systems (US) to improve orthopedic care and MedTech devices using new ideas, hoping to give patients better health results. The company holds a significant market share in over 60 nations across diverse territories such as North America, Asia Pacific, Europe, and Africa. For more information, [ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=5230937&utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=orthopedicimplantsmarket ] Media Contact Company Name: MarketsandMarkets Trademark Research Private Ltd. Contact Person: Mr. Rohan Salgarkar Email:Send Email [ https://www.abnewswire.com/email_contact_us.php?pr=orthopedic-implants-market-to-hit-usd-2647-billion-by-2029-with-48-cagr ] Phone: 18886006441 Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 City: Florida State: Florida Country: United States Website: https://www.marketsandmarkets.com/Market-Reports/orthopedic-implants-market-5230937.html This release was published on openPR.Emerson Electric Co. stock underperforms Wednesday when compared to competitors despite daily gains
Abstract Security Joins Forces with Analytica42 to Supercharge Integration Delivery including integration to Google SecOps PlatformAfter institutions for people with disabilities close, graves are at risk of being forgottenSystem Integration Services Market size is set to grow by USD 140.69 billion from 2024-2028, need for enhanced business process efficiency boost the market- Technavio
Include music in film’s planning stage: French composerGrindr to Participate in the Raymond James 2024 TMT & Consumer Conference
Quick response saves Saskatchewan hockey player’s life after neck slashed - 650 CKOM News Talk SportsCrescent Energy Announces Pricing of Upsized $400 Million Private Placement of Additional 7.625% Senior Notes Due 2032
Teacher Dies After Bat Attack in ClassroomWith each team coming off a come-from-behind win, West Virginia and North Carolina Central square off Tuesday night in Morgantown, W.Va. West Virginia (6-2) has won two straight games and is in the midst of a 16-day, four-game homestand that kicked off with a 73-60 win over Georgetown in the Big 12-Big East Battle on Friday night. North Carolina Central (4-7) comes off a 78-77 road win over Gardner-Webb on Saturday night. Javon Small led the Mountaineers with a game-high 26 points against Georgetown as they overcame a second-half deficit with a decisive run. "The way we played in the second half (against Georgetown), I'll take that team everywhere," West Virginia coach Darian DeVries said. "You have to be able to do that every single night, every single possession you don't always get to go on a 16-0 run to pull you out of it. That's where we are still growing as a team." Eduardo Andre was questionable for the Georgetown game after he missed the Mountaineers' 83-76 overtime win against Arizona on Nov. 29. But the fifth-year senior center returned with four points, three rebounds and four blocks. "It was good to have him back in the lineup for a reason," DeVries said. "That presence, especially defensively and the ability to block shots, that's a huge deal for us." Against Gardner-Webb, Po'Boigh King led NCCU with 28 points, well above his 17.4 points per game average, as the Eagles rallied from a 17-point second-half deficit to win on a late 3-pointer from Isaac Parson. On offense, the Eagles take care of the ball. They are seventh in the nation in turnover margin at plus-7.5 per game. They seek extra possessions on defense and are second nationally with 18.9 turnovers forced per game "We're good enough, we just need to fine tune some things," NCCU coach LeVelle Moton said. "We've got to cross some T's, dot some I's and close. We can't be a really good basketball team until we get the mindset that when winning time presents itself in the last five minutes, (the other team) has to earn it." --Field Level Media
Pam Bondi, Donald Trump's pick to be attorney general, is a staunch ally of the former president, defending him against impeachment during his first term and pushing his false claims of election fraud as he sought to cling on to the White House. The 59-year-old former Florida attorney general, if confirmed by the Senate, will now serve as the top law enforcement official in a second Trump administration. "For too long, the partisan Department of Justice has been weaponized against me and other Republicans -- Not anymore," Trump wrote on his Truth Social network. "Pam will refocus the DOJ to its intended purpose of fighting Crime, and Making America Safe Again." Bondi's nomination means the top ranks of the Justice Department will be filled by Trump loyalists, as the president-elect has named three of the lawyers who defended him in his multiple criminal cases to its other high-ranking roles. Trump tapped Bondi to be attorney general on Thursday after his first pick, firebrand ex-Florida lawmaker Matt Gaetz, dropped out amid sexual misconduct allegations and doubts that he could obtain Senate confirmation. A graduate of the University of Florida with a law degree from Stetson University, Bondi served as a prosecutor for 18 years before being elected attorney general of the "Sunshine State" in 2010, the first woman to hold the post. Bondi, a native of Trump's adopted home state of Florida, was reelected to a second term in 2014. As attorney general, Bondi notably fought opioid addiction and human trafficking while taking a tough stance on crime and supporting the death penalty. She sued BP for the 2010 Deepwater Horizon oil spill in the Gulf of Mexico and obtained more than $2 billion in economic relief for Florida, according to her biography page at Ballard Partners, a powerful lobbying firm where she has worked after leaving office. While serving as attorney general, Bondi was drawn into a controversy involving Trump when she declined in 2013 to join a multi-state prosecution accusing Trump University of fraud. It emerged later that Bondi's reelection committee had received a $25,000 donation from the charitable Trump Foundation. Both Trump and Bondi denied any wrongdoing. Bondi joined Trump's legal team during his first impeachment trial, in which he was alleged to have pressured Ukrainian President Volodymyr Zelensky to find political dirt on his 2020 election opponent, Democrat Joe Biden. Trump was impeached by the Democrat-controlled House of Representatives but acquitted by the Republican-majority Senate. After the 2020 election, Bondi made television appearances on behalf of Trump and pushed to de-legitimize vote counting in battleground states as part of the push by the former president to overturn the results of the vote. Bondi has also criticized the criminal cases brought against Trump, appearing in solidarity at his New York trial, where he was convicted of falsifying business records to cover up hush money payments to a porn star. At Ballard Partners, Bondi has done work for Amazon, General Motors and Uber and as a registered lobbyist for the oil-rich Gulf nation of Qatar, according to press reports. She is also a member of the America First Policy Institute, a Trump-aligned right-wing think tank. cl/dw
Formula 1 expands grid to add General Motors' Cadillac brand and new American team for 2026 seasonA-1 Septic and Drain Field Repairs Establishes Industry Leadership in Advanced Drain Line Solutions
Indian IT services hiring to remain low till growth momentum picks up by H2 FY26: ICRA NEW DELHI: Hiring in the Indian IT services industry is expected to remain low-key in the near term until the growth momentum picks up by H2 FY2026, according to ICRA. The formation of the new government in the US may create some policy uncertainty in the immediate term and thus will remain monitorable, it said. Lower discretionary tech spends by customers in key markets of the US and Europe, amid an uncertain macroeconomic environment, has led to moderation in demand for Indian IT services companies over the last 6-8 quarters. Factors such as lower employee attrition and a focus on increasing employee utilisation also contributed to the slowdown in hiring. “While there has been some recovery in Q2 FY2025, ICRA expects hiring to remain low in the near term until the growth momentum picks up by H2 FY2026,” the agency said. Moderation in demand coupled with the increase in utilisation of excess manpower added during FY2022-FY2023 exerted pressure on hiring by IT services companies through FY2024 and Q1 FY2025. Coupled with an increase in attrition levels, this also led to negative net employee addition for the seven quarters till Q1 FY2025 for ICRA’s sample set companies, which includes HCL Technologies, Infosys, Tata Consultancy Services, Tech Mahindra and Wipro Ltd. As Gen AI makes rapid inroads, all leading IT services companies are upskilling their employees as they explore AI-driven business opportunities. This is likely to lead to an overall moderation in fresh hiring, as compared to pre-Covid levels, it predicted. ICRA said that the impact of higher adoption of Generative AI (Gen AI) on improving employee productivity is expected to be visible over the next few years. Average revenue in USD per employee for the sample set has largely been stable at around USD 50,000 over FY2020-FY2024. However, this metric will show steady improvement if assessed on revenue in rupee terms due to depreciation of the rupee against some key foreign currencies over this period. The last twelve-month (LTM) attrition rate had peaked at about 23 per cent during Q4 FY2022 and Q1 FY2023, led by significant hiring and subsequent demand-supply mismatch. However, it sequentially tapered with lower hiring by IT services companies amid moderation in demand in key markets of the US and Europe. The LTM attrition rate for ICRA’s sample set companies started stabilising from Q3 FY2024 at about 13 per cent, much lower than the pre-pandemic level of about 18 per cent in Q1 FY2020 for the sample set companies. PTIAbstract Security Joins Forces with Analytica42 to Supercharge Integration Delivery including integration to Google SecOps Platform
Trump's nominee for attorney general a longtime allySPORTING LISBON 1-5 ARSENAL Mikel Arteta promised to send out a ruthless team to end his poor run of European away days and how the Arsenal manager delivered. This deserved dismantling of one of Europe’s most feared teams was what can best be described as a statement win and their best under Arteta in the Champions League. Talk here in Lisbon over the past few days was that the club that gave us Cristiano Ronaldo as a player and more recently Ruben Amorim as a coach had never been better and virtually unplayable at home. They came into the match unbeaten and second to only Liverpool in the new format Champions League table, fresh from thrashing Manchester City here last time out. Arsenal scored only their second away win in eight Champions League trips aided by three first half goals via Gabriel Martinelli, Kai Havertz and Gabriel. They withstood a second half comeback goal from Goncalo Inacio and a 65thminute Bukayo Saka penalty killed the game off. The size of the win lifts Arsenal from 14th to eighth in the table. With home games against Monaco and Dinamo Zagreb followed by a trip to Girona yet to come, they are on course to avoid the inconvenience of a February play-off and qualify automatically for the last 16 of this season’s edition of the competition. Arteta has only an FA Cup to his name to date but knows the fans and hierarchy demand more to really return Arsenal to the top of the top table. How realistic that is remains to be seen. It is hard to challenge the notion that the Spanish coach has restored the club’s relationship with their supporters worldwide and returned the club to the levels they need to be at for the first time since Arsene Wenger left seven years ago. Regularly challenging for the Premier League title and routinely competing in and emphatically winning on Champions League nights such as these as a matter of course. The transformation is not complete, but it is not far off. Lisbon were rattled by the quality of Arsenal’s start, the way they moved the ball so precisely at pace. The decision to go out on the front foot paid off inside the opening seven minutes when Martinelli put them in front. Jurrien Timber worked himself clear on the right and sent in a tantalising low right-foot cross with a bit of curl that drew the keeper out while also taking the ball away from him. Kai Havertz looked set to cash in but was blocked by defender Diomande and Martinelli stole in at the far post to score his second goal in as many games. The second goal, after 22 minutes, also came down the right and was also a quality move. In form Thomas Partey sent Bukayo Saka clear with a chip into the Sporting area and the England winger prodded the ball through Franco Israel’s legs for Havertz to tap in a ball that would probably have gone in anyway. The stunned Sporting supporters responded by letting off a bunch of green and white smoke bombs and flashing fireworks over the head of undeterred Arsenal keeper David Raya. Arsenal continued to look the more dangerous side in the smoke even when Sporting tried to up the pace of their game. As the Portuguese laboured the Arsenal supporters stationed high up in the Estadio Jose Alvalade taunted the locals with chants of ‘we want more fireworks.’ A warning against complacency for fans and players alike came in the form of a run and shot by Geovany Quenda, which Raya tipped over the bar just before half-time. Raya snuffed out the danger from the corner too and moments later was dancing around his area in celebration when Gabriel headed in from a Declan Rice corner with the very last touch of the first half. The Brazil central defender sprinkled some salt on the wounded Lisbonites by celebrating in front of their fans in the style of their Swedish goalscoring hero Viktor Gyokeres. The highly coveted striker, said to be firmly on Arsenal’s radar too, touched the ball only 18 times in the first half, three of them from kick-offs. Sporting came out like a rocket at the start of the second half as a Hidemas Morita shot earned them a quick corner. Goncalo Inacio scored when the ball was sent back in and with only two minutes of the second period played it was game on all over again. Arsenal diligently slowed the game down and Saka buried his spot kick and any hopes of a comeback after Martin Odegaard was hacked down from behind in the penalty area. Substitute Leandro Trossard’s 82nd minute header from the rebound of a Mikel Merino shot prompted an early emptying of the stadium. Sporting Lisbon: Israel 6, St Juste 5, Inacio 6 (Reis 88), Diomande 5, Araujo 5 (Catamo 68), Morita 6 (Harder 78), Quenda 6, Hjulmand 6, Edwards 5 (Braganca 68), Gyokeres 7, Trincao 6. Subs not used: Kovacevic, Callai, Fresneda, Esgaio, Brito, Simoes, Monteiro, Couto. Arsenal: Raya 8, Timber 8, Saliba 8, Gabriel 8 (Kiwior 84), Calafiori 6 (Zinchenko 78), Odegaard 8 (Nwaneri, 78), Partey 8, Rice 7 (Merino 70), Saka 8, Martinelli 8 (Trossard 70), Havertz 7. Subs: Neto, Setford, Tierney Lewis-Skelly, Jorginho, Sterling, Jesus. Referee: Szymon Marciniak (POL) 6.SUNBURY — Shikellamy students had the opportunity to listen to a 23-year-old New Jersey genealogist who helped the state police solve the oldest cold case in the state. Shikellamy Police Chief Shawn Williams was able to get Eric Schubert, now of Lancaster, to speak to the law enforcement club last week about how he helped troopers, including Williams, a retired corporal in the state police, solve the 57-year-old cold case of 9-year-old Marise Chiverella by matching DNA to a deceased suspect. Chiverella was found dead March 18, 1964, in a strip mine pit, near Hazleton, Luzerne County, police said. State police said James Paul Forte, 38, a bartender with a history of sexual assault, kidnapped the child, then raped and killed her. Police said Forte died of natural causes in 1980. Police said Forte, who was 22 at the time of the murder, had no known connection to the little girl or her family. State police said the girl left her home on March 18 and was taken by Forte. The case remained open for 57 years and thanks to Schubert, a DNA match was discovered and it was a perfect match to Forte whose DNA was discovered on the child's body. Generations of state police investigators pursued Marise’s killer — more than 230 members of the department were involved in the probe at one time or another — but Forte’s name did not come up until 2020. By that time, new DNA technology had established a distant family connection to Forte, and Schubert, a college student at the time and expert in genetic genealogy who had volunteered to work the case, put together an extensive family tree that helped investigators narrow their suspect list. Schubert told Shikellamy students on Friday he began researching genetic genealogy when he was 8 years old. In early 2020, Schubert said he saw newspaper articles on the case and offered his assistance to Pennsylvania State Police. Troopers said they checked into Schubert’s background and discovered he had helped other law enforcement across the country in cold cases. Schubert was introduced to the case and met Williams who had been working with the Luzerne County District Attorney’s Office in 2019, with Deputy District Attorney Dan Zola and several other state troopers. After narrowing down the suspect list, Forte's body was exhumed from a cemetery near Hazleton and DNA was taken, police said. "This was a great opportunity for me that I don't really get," Schubert said about speaking to the students inside the Shikellamy High School auditorium via Zoom. "They were so interested in everything and I loved it because I remember sitting in their seats and listening to people speak who inspired me." Williams said more than 100 students participated in the session. "The Law Enforcement Club presentation by Eric Schubert was extremely interesting and on point," he said. "Not only did we discuss a cold case homicide and his involvement in solving the case but Eric also related his life successes and career pathway to a generation of students closer to his age. Eric's story, to get where he is, was very inspirational to our students. His mindset is to not let anything or setbacks stand in your way, that was his message." Williams said the presentation also utilized technology. "It was important to open up this presentation to not only law enforcement members but to science-minded individuals in our school. We included Mrs. Katie Wolfgang's honors biology class and they were in attendance for this presentation," Williams said. Assistant Principal Stephen Hafele said it was a great learning experience for students. "It was a wonderful opportunity for our students to have an in-depth look into some of the methods to solving crimes," he said. "The genealogical methods shared by Eric and the connection to science was great for our Honors Biology students to make real-world connections to what they are learning."
UnitedHealthcare CEO kept a low public profile. Then he was shot to death in New York
Star-studded evening featured Tamron Hall , Halsey, and Honored LRA Founder Robert Wood Johnson and Verizon Chairman and CEO Hans Vestberg NEW YORK , Nov. 26, 2024 /PRNewswire/ -- The 2024 Lupus Research Alliance (LRA) Breaking Through Gala raised nearly $3 million for lupus research, bringing the hope for a world free of lupus closer with every dollar. Emceed by two-time Emmy Award-Winning host and bestselling author Tamron Hall , the evening included a commanding performance by GRAMMY ® nominated genre-blending singer, songwriter, and activist Halsey . In welcoming the 500 guests, Tamron Hall explained why she continues to support the Lupus Research Alliance. "Almost everyone in this room knows what it means to live with lupus only too well – you cope with it every day, or you see its effects on someone you love – and sometimes that's even harder to bear," Hall commented. "I too watch several people I am close to struggle with this disease. Like you, I am here tonight, helping increase disease awareness and raise funds for the most promising research because that is how we can best help the people we care so much about." This spring, Halsey bravely revealed her lupus diagnosis, raising broad public awareness among 30+ million Instagram followers and beyond, referring them to the Lupus Research Alliance to learn more. On the heels of releasing a powerful album about struggling with chronic illness, including lupus, Halsey shared her lupus journey with Gala guests before performing. "Opening up about my own lupus diagnosis a few months ago has brought me a sense of comfort, knowing I'm now part of such a passionate and supportive community," said Halsey. "I hope that through my music, I can help amplify the strength we all share and the brighter future we're working toward." LRA President and CEO Albert T. Roy commented, "This year's Gala celebrates the Heart of Innovation – inspiring words that eloquently convey why so many support the work of the LRA. Our organization was founded and continues to be fueled by people like this year's co-honorees The Honorable Robert Wood Johnson and Verizon Chairman and CEO Hans Vestberg who believe in the power of science and technology as the best way to help those living with lupus. Our mission is driven by that kind of passion, getting to the very heart of what causes lupus and bringing forth innovative discoveries that are transforming lives." Why improved treatments are still so urgently needed was poignantly illustrated by speaker Jenny Zwick along with her husband and Board member Spencer sharing how lupus has affected their lives. Special Supporters Recognized for Contributions Mr. Roy also thanked Lady Gaga and Selena Gomez for their support as Gala Honorary Co-Chairs along with the event Co-Chairs: Ira Akselrad, President of The Johnson Company and Lupus Research Alliance Board Chair; Bob Pittman , Chairman and CEO of iHeartMedia, Inc.; and Spencer J. Zwick ; Co-Founder and Managing Partner of Solamere Capital. Philanthropist and Honorary Gala Co-Chair Michael R. Bloomberg addressed the audience in a special videotaped message of enduring support for the lupus cause as well as a tribute to the organization's late Board of Directors Co-Chair Richard K. DeScherer who passed away this past year. Robert Wood Johnson Honored for Founding the LRA to Improve the Future for Daughter Jaime LRA Founding Chairman The Honorable Robert Wood Johnson started the Lupus Research Alliance (then the Alliance for Lupus Research) in 1999 to find answers when his daughter was first diagnosed with lupus as a young child. Ambassador Johnson explained, "Back then, there was not even one treatment developed for lupus and few scientists were working in the field. Funding more research to improve treatment was clearly critical, not just for my daughter, but for millions more. I am proud that our work laid the foundation for two of the three current lupus-specific treatments, and for many more now in clinical development." Honoree Hans Vestberg Recognized for Verizon Support of Lupus Research As Chairman and CEO of Verizon, Hans Vestberg was also honored for the company's long-standing commitment to furthering lupus research. In addition to many years supporting the LRA Walk program directly, Verizon is a cornerstone sponsor of the New York Jets, contributing to the Jets Foundation which is committed to the LRA as one of its primary causes. In addition to thanking the speakers on stage, Mr. Roy also applauded the entire lupus community who donate for LRA-funded research, advocate for federal research funding, raise disease awareness and participate in clinical research – all doing what they can to improve current treatment and ultimately free the world of lupus. He also pointed everyone's attention to the lighting of the iconic Empire State Building which lit up NYC's skyline in the colors of lupus research – purple and red. About Lupus Lupus is a chronic, complex autoimmune disease that affects millions of people worldwide. In lupus, the immune system, meant to defend against infections, produces autoantibodies that mistake the body's own cells as foreign, causing other immune cells to attack organs such as the kidneys, brain, heart, lungs and skin, as well as blood and joints. Ninety percent of people with lupus are women, most often diagnosed between the ages of 15-45. Black, Latinx, Indigenous, Asian and Pacific Islander people are disproportionately affected by lupus and more likely to experience severe lupus symptoms. About the Lupus Research Alliance The Lupus Research Alliance is the largest non-governmental, non-profit funder of lupus research worldwide. The organization aims to transform treatment by funding the most innovative lupus research, fostering diverse scientific talent, and driving discovery toward better diagnostics, improved treatments and ultimately a cure for lupus. Because the Lupus Research Alliance's Board of Directors funds all administrative and fundraising costs, 100% of all donations goes to support lupus research programs. For more information or to donate to lupus research, visit the LRA at LupusResearch.org and on social media at: X , Facebook , LinkedIn , and Instagram . View original content to download multimedia: https://www.prnewswire.com/news-releases/2024-lupus-research-alliance-gala-raises-millions-to-improve-lives-of-people-with-lupus-302316842.html SOURCE Lupus Research AllianceSrini Venkatramani Joins Blend As Head of Product, Technology, and Customer OperationsLocalCableDeals Highlights Essential Instagram Business Tools for Streamlined Success 12-10-2024 12:46 AM CET | Business, Economy, Finances, Banking & Insurance Press release from: ABNewswire Instagram has become a global sensation since its inception, captivating users of all ages and demographics. But beyond its social allure, Instagram offers substantial benefits for businesses looking to expand their reach and engage with their audience. Wondering how this platform can elevate your business? Let's dig into its advantages and potential. So, for starters, apart from serving as a platform for content display, Instagram facilitates seamless interactions through features like sharing, liking, and commenting on posts. It fosters a sense of community, allowing businesses to connect with their target audience and vice versa. Moreover, Instagram provides robust analytics tools, enabling businesses of all sizes to track their Return on Investment (ROI) effortlessly. From monitoring link clicks to assessing leads and conversions, Instagram offers comprehensive insights to refine your marketing strategies. Continuously evolving to meet the demands of users and businesses alike, Instagram introduces new features and enhancements regularly, further enhancing its value proposition. To help you leverage Instagram effectively for your business, we have gathered a list of apps designed to elevate your Instagram marketing game. ByClick Downloader It emerges as a go-to solution for businesses heavily invested in video content. Renowned worldwide, this downloader is tailored for seamless offline streaming and video downloads. It offers a lot of resolution options, from 720p to 8K. ByClick Downloader's versatility makes it an invaluable asset for businesses seeking to enhance their Instagram marketing efforts. However, it's essential to ensure a reliable internet connection with great speeds and customer service for optimal performance. Consider providers like Xfinity, known for their fast and dependable service. You can call support by dialing the Xfinity phone number [ https://www.localcabledeals.com/xfinity/customer-service ] in case of any issue and they will cater to them timely. With a robust internet connection, coupled with the right tools like ByClick Downloader, businesses can maximize their Instagram marketing potential and stay ahead in today's competitive landscape. GoPro Quick App This amazing app is a revolutionary tool that addresses the common challenge of efficiently managing and curating an extensive library of photos and videos. Catering to individuals and businesses alike, this innovative software simplifies the process of creating compelling visual content by automating the extraction of key moments from multimedia files. Whether you are an adventure enthusiast capturing adrenaline-pumping moments or a business seeking to showcase your products or services in action, the GoPro Quick App offers a seamless solution for transforming raw footage into polished, shareable content. One of the standout features of the GoPro Quick App is its ability to identify and highlight the most impactful moments within videos and photos. Using advanced algorithms, the app automatically detects key elements such as fast-paced sequences, jumps, and steady footage, ensuring that users can easily pinpoint the highlights of their content. Additionally, the app's intuitive interface empowers users to customize their edits, allowing for personalized touches that align with their brand identity or creative vision. Sprout Social This one stands out as a versatile and enduring platform, having evolved into a robust tool over its tenure in the social media sphere. Beyond its core function of social media management, Sprout Social has an extensive array of analytics and reporting features, making it indispensable for businesses seeking to maximize their online presence. Particularly noteworthy are its social media management and SEO tools, which have become essential for businesses of all sizes in today's digital landscape. For small and medium-sized businesses (SMBs) in particular, Sprout Social offers a comprehensive package that seamlessly integrates social tools with advanced analytics, providing users with a holistic solution for their social media needs. With its user-friendly interface and diverse feature set, this tool caters to both beginners looking to establish their online presence and seasoned professionals aiming to enhance their social media engagement. Piktochart You might have heard about this one already. Piktochart revolutionizes the creation of visually striking infographics, empowering users with intuitive tools and a seamless online platform. With its user-friendly interface and straightforward controls, Piktochart simplifies the process of transforming data into captivating visual content. While originally targeted towards professionals in the corporate realm, Piktochart's versatility extends to educational applications, offering educators and students alike a powerful tool for creating engaging visual presentations. By harnessing the capabilities of Piktochart, businesses can convey complex information in an accessible and visually appealing manner, enhancing their online visibility and engagement. Bottom Lines This brings us to the end of this post. By incorporating these tools into their social media strategy, businesses can elevate their online presence, drive engagement, and foster meaningful connections with their audience. Dive into these tools today and experience the transformative impact they can have on your business. If you have any questions or feedback, feel free to share them in the comments section below. Media Contact Company Name: Localcabledeals Contact Person: David Samtih Email:Send Email [ https://www.abnewswire.com/email_contact_us.php?pr=localcabledeals-highlights-essential-instagram-business-tools-for-streamlined-success ] City: New York Country: United States Website: https://www.localcabledeals.com This release was published on openPR.
St. Paul-based Bremer Bank to be acquired in $1.4 billion merger with Old National BankSimon Webb and Duncan Nicholls Over the past week, I’ve been planning a bold move on Micron Technology, Inc. ( NASDAQ: MU ), and today, Friday, December 13th, I finally pulled the trigger. It's a two-step play: first, I'm shorting the company with deep Analyst’s Disclosure: I/we have a beneficial short position in the shares of MU either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.